The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
500 jobs Number of planned job creations
Announcement Date
23 July 2018
Employment effect (start)
23 July 2018
Foreseen end date
Description
Pharmaceuticals manufacturer, Abbott Ireland, is to hire 500 people 'over the next few years' in Donegal town.
The roles will be in research and development.
The Abbott plant in Donegal currently has 200 employees. Abbott Ireland employs 3000 people in Ireland, across nine sites.
The Donegal plant specialises in treatments for diabetes, manufacturing and distributing Abbotts’ FreeStyle and FreeStyle Lite brands of blood glucose test strips.
Abbott was granted planning permission earlier this year to expand its manufacturing site in Donegal, enabling the jobs expansion.
Sources
Citation
Eurofound (2018), Abbott Ireland, Business expansion in Ireland, factsheet number 94733, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/94733.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
